Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Avid Bioservices, Inc. (NASDAQ: CDMO) to funds managed by GHO Capital Partners LLP and Ampersand Capital Partners ...
Nektar Therapeutics today reported financial results for the third quarter ended September 30, 2024. Cash and investments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback